Telematic Support in Early Intervention on Infants At Risk of Neurodevelopmental Delays
NCT ID: NCT06608576
Last Updated: 2024-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
60 participants
INTERVENTIONAL
2024-02-15
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Invasive Neuromodulation in Children With Neurodevelopmental Disorders
NCT05265702
Physical Therapy Treatment on Children and Adolescents With Neurological Pathologies
NCT05313295
Effectiveness of Vojta Therapy in Motor Development of Preterm Children
NCT01838278
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
NCT06579027
Transcranial Direct Current Stimulation and Gamified Rehabilitation for Upper Limb Function in Pediatric Brain Damage
NCT06214364
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Treatment
participants will receive face-to-face early intervention treatment on physical therapy area once a month for two months.
Face-to-face standard treatment
Individualized early intervention treatment on physical therapy area as usual in the early intervention facilities once a month for two months. Instructions will be given to the parents for follow-up at home to stimulate the baby's motor development until next face-to-face session.
Telematic Support
Participants will receive weekly telematic early intervention sessions at home via video conferencing for two months.
Telematic Support
The physiotherapist in charge of the telematic sessions will review and guide in real time through WhatsApp platform, the performance and active participation of the parents in the therapeutic activities being asked to follow-up at home in the face-to-face appointment, correcting, as necessary.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Face-to-face standard treatment
Individualized early intervention treatment on physical therapy area as usual in the early intervention facilities once a month for two months. Instructions will be given to the parents for follow-up at home to stimulate the baby's motor development until next face-to-face session.
Telematic Support
The physiotherapist in charge of the telematic sessions will review and guide in real time through WhatsApp platform, the performance and active participation of the parents in the therapeutic activities being asked to follow-up at home in the face-to-face appointment, correcting, as necessary.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At risk of neurodevelopmental delays or disorders.
* Whose family has a cell phone with WhatsApp Application installed and internet to be able to carry out the telematic tests.
Exclusion Criteria
* Minor infants with diagnosis of neuromotor injury, visual and auditory sensory disorders or congenital anomalies.
* Infants with orthoses and/or prostheses.
* Children with health complications that enable the child's participation in the study.
* Not spanish-speaking parents.
3 Months
12 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario San Cecilio de Granada
UNKNOWN
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marie Carmen Valenza
PT, PhD, Professor at University of Granada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario San Cecilio de Granada
Granada, Granada, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBL-ATPO-2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.